Press release
Global Biochips Market Research Update, Size Estimation, Future Scope, Revenue Opportunities and Regional Forecast to 2032
Biochips Market
Click To get SAMPLE PDF (Including Full TOC, Graphs & Charts, Table & Figures)@ https://www.emergenresearch.com/request-sample/2720
Key Drivers Fueling Market Growth
The rise in biosensor applications for disease diagnosis and personalized treatments is a primary driver of the biochips market. Biochips, equipped with various biosensors, enable the detection and screening of enzymes, proteins, DNA, antibodies, and other biological materials. They are being increasingly used to evaluate patients' health profiles, aiding in the diagnosis of noncommunicable diseases (NCDs) like cancer and diabetes. According to the World Health Organization (WHO), NCDs account for 74% of all global deaths, underscoring the growing need for advanced diagnostic tools such as biochips.
Moreover, substantial investments and funding from pharmaceutical companies, research institutions, and governments are also accelerating market growth. The European Union's Horizon Europe program, with a commitment of USD 7.72 billion for health research, and Israel's Innovation Authority's allocation of USD 31 million for biochip-related research and development are prime examples of this trend.
Collaborative Innovation and AI Integration
Increased collaboration between biotechnology companies and research services is pushing the development of next-generation biochip technologies, such as Lab-On-A-Chip (LOC) and Organs-On-Chips (OoCs). Companies like DLOC Biosystems are collaborating with others to create automated human-on-chip systems that promise enhanced research outcomes.
Additionally, the integration of Artificial Intelligence (AI) and Machine Learning (ML) in biochip technology is revolutionizing the healthcare industry by enabling faster, more accurate disease detection. AI and ML algorithms are used to analyze complex datasets, identifying patterns that aid in personalized treatment recommendations.
Challenges: Regulatory and Cost Barriers
Despite its promising growth, the biochips market faces some challenges. Regulatory hurdles, particularly in regions with stringent compliance requirements like the U.S. and Europe, are impacting the commercialization and development timeline of biochips. The U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) play critical roles in the approval process, which can slow down market entry.
Additionally, the high costs associated with biochip research, development, and acquisition due to complex technologies like sensing chemistry and microarrays present a significant barrier, particularly for smaller companies.
Request For An Discount@ https://www.emergenresearch.com/request-discount/2720
Market Segment Insights
Lab-On-A-Chip Leads in Chip Type Segmentation
The lab-on-a-chip segment dominated the global biochips market in 2022, offering a cost-effective and rapid solution for diagnostics and chemical synthesis. This technology is widely used in human diagnostics and DNA analysis, contributing to its substantial market share. The healthcare industry's growing reliance on this technology for faster, more precise results is further driving its dominance.
The microarray segment, though smaller, is also expected to see moderate growth due to its ability to genotype thousands of loci simultaneously, aiding in the identification of chromosomal regions related to specific diseases like cancer.
Drug Discovery Dominates Application Segmentation
The drug discovery segment is poised to account for a significant portion of the biochips market. Biochips' ability to identify genetic attributes linked to diseases makes them invaluable in pharmaceutical research for identifying potential drug targets. Strategic partnerships, such as ACRO Biosystems' collaboration with Diagnostic Biochips, are also contributing to advancements in drug discovery, particularly in the neuroscience field.
Meanwhile, the clinical diagnostics segment is projected to grow steadily as biochips become increasingly essential in diagnosing genetic and chronic diseases. Biochip technology continues to evolve, with new developments in DNA, RNA, and protein-based biochips expanding their diagnostic capabilities.
Biochips Top Companies and Competitive Landscape
The global biochips market is consolidated, with several key players accounting for the majority of market revenue. Major players are deploying various strategies, entering mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing new biochips products and solutions.
Some major players included in the global biochips market report are:
Abbott
Agilent Technologies
Bio-Rad Laboratories, Inc.
Danaher Corporation
Standard BioTools
Thermo Fisher Scientific Inc.
PerkinElmer Inc.
Micronit B.V.
Illumina, Inc.
BIOMÉRIEUX
QIAGEN
Synbio Technologies
Hoffmann-La Roche Ltd.
GE HealthCare
Cepheid
BioNTech SE
Personalis, Inc.
NantHealth, Inc.
Oxford Nanopore Technologies
Bionano Genomics
Interested in knowing more relevant information? Click here: https://www.emergenresearch.com/industry-report/biochips-market
Biochips Latest Industry Updates
On 1 August 2023, Opteev Technologies announced the filing of a patent for a new multiplex biochip that can precisely identify Flu, SARS-CoV-2, RSV and respiratory pathogens. The new polymer-based biochip is intended for testing multiple pathogens that can cause these respiratory infections.
On 19 June 2023, ACRO Biosystems Anuero partnered with Diagnostic biochips to launch in vivo electrophysiology solutions for neuroscience research. Together, the two companies are committed to a collaborative effort to accelerate neurological drug discovery and commercialization.
For the purpose of this report, Emergen Research has segmented the global biochips market on the basis of chip type, product, application, end-use, and region:
Chip type Outlook (Revenue, USD Billion; 2019-2032)
Lab on a chip
Micro array
Product Outlook (Revenue, USD Billion; 2019-2032)
Instruments
Reagents and consumables
Application Outlook (Revenue, USD Billion; 2019-2032)
Clinical diagnostics
Drug discovery
Genomics and proteomics
Others
End-Use Outlook (Revenue, USD Billion; 2019-2032)
Biotech companies
Hospitals
Diagnostics center
Research institutes
Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of Middle East & Africa
Buy the full research report at @ https://www.emergenresearch.com/select-license/2720
Look Over transcripts provided by Emergen Research
Biochips Market Size@ https://www.emergenresearch.com/industry-report/biochips-market/market-size
Biochips Market Share@ https://www.emergenresearch.com/industry-report/biochips-market/market-share
Biochips Market Trends@ https://www.emergenresearch.com/industry-report/biochips-market/market-trends
Biochips Regional Market Demand@ https://www.emergenresearch.com/industry-report/biochips-market/regional-market-demand
Biochips Market Analysis@ https://www.emergenresearch.com/industry-report/biochips-market/market-analysis
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Biochips Market Research Update, Size Estimation, Future Scope, Revenue Opportunities and Regional Forecast to 2032 here
News-ID: 3687108 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Biochip
Biochip Market Size, Share, Growth & Industry Report Analysis 2032
Biochip Market Overview
The biochip market refers to the use of microchips that integrate biological molecules such as DNA, proteins, and enzymes for diagnostics, drug development, and genetic testing. These compact devices offer high-throughput screening and multiplexing capabilities, enabling advancements in personalized medicine and disease detection. With the rise in chronic diseases, such as cancer, diabetes, and cardiovascular diseases, biochips are becoming essential in early diagnosis, monitoring, and precision treatment. As…
Biochip Market Size, Share, Report and Forecast 2024-2032
The global biochip market size was valued at USD 6.7 billion in 2023, driven by the rising prevalence of chronic diseases, and increased preference for personalized medicine across the globe. The market is expected to grow at a CAGR of 14.36% during the forecast period of 2024-2032, with the values likely to rise from USD 14.2 billion in 2024 to USD 41.4 billion by 2032.
Biochip: Introduction
Biochips are miniature laboratories that…
Global Automatic Biochip Reader Market Research Report 2023-2029
Automatic Biochip Reader report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Automatic Biochip Reader market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Tumor Detection and Drug Screening are the major drivers for the industry.
Global Leading Market Research Publisher QYResearch announces…
Liquid Biochip Analyzer Market Analysis,Demand,Trends and Forecast 2029
Global Info Research announces the release of the report "Global Liquid Biochip Analyzer Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029" . The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets.…
Global Biochip Reader Market - Opportunities & Forecasts, 2020-2029
Dhirtek Business Research and Consulting recently released its most comprehensive research report to date on the global biochip reader market. Through extensive research, analysts have provided an extensive look into the market's drivers and restraints, and identified the key milestones and trends that will shape its future.
Primary and secondary research methods were used to create this in-depth report. Through the analysis of the research, Dhirtek was able to identify the…
Biochip Market 2022 | Detailed Report
The Biochip research report provides a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The data thus presented is reliable, comprehensive and the result of extensive research both primary and secondary. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. Moreover, the data underlines the primary and secondary drivers, market…
